At a glance
ClinicalIndex Comparison RecordN/ACompleted· 30 enrolled
Drug / intervention
Panoptixdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of Quality of Vision and Spectacle Independence With Bilateral Implantation of the AcrySof® Panoptix® Intraocular Lens
In Brief
An observational study evaluating Panoptix for Cataract. Completed, enrolled 30 participants across 1 site.
Detailed Summary
This is a study to assess the spectacle independence and quality of vision of patients receiving the AcrySof® Panoptix® Intraocular lens (IOL) after uneventful cataract surgery.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCataract
CountriesUnited States
CollaboratorsScience in Vision
Timeline
N/ACompletedFinished
2020202120222023202420252026
Enrollment StartOct 2019
First PostedOct 2019
Primary CompletionFeb 2021
TodayJul 2026
First PostedOct 14, 2019
Enrollment StartOct 3, 2019
Primary CompletionFeb 16, 2021
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 6.7 years ago
Interventions
Panoptixdevice
Alcon Acrysof(R) Panoptix(R) intraocular lens (IOL)